文献速递儿科影像腹部MR

儿童腹部肿瘤风险分层的酰胺质子转移成像研究

Risk stratification of abdominal tumors in children with amide proton transfer imaging.
PubMed 文献 · Eur Radiol · 2022-01-15

前瞻性纳入133例疑似腹部肿瘤的未治疗患儿,最终分析57例(神经母细胞瘤24例、Wilms瘤18例、肝母细胞瘤15例),评估APT MRI预测风险分组并与定量T1、T2 mapping比较。APT信号在高危与低危神经母细胞瘤间差异显著(p < .001),但在Wilms瘤(p = .69)和肝母细胞瘤(p = .35)中无显著差异;APT鉴别低危与高危神经母细胞瘤、Wilms瘤、肝母细胞瘤的AUC分别为0.93、0.58、0.71,定量T1和T2的AUC为0.61-0.70。

要点

  • APT信号在高危神经母细胞瘤显著高于低危组(p < .001)。
  • APT鉴别低危与高危神经母细胞瘤的AUC为0.93。
  • APT在Wilms瘤和肝母细胞瘤风险分层中无显著差异。

核心结论

  • APT MRI是术前对儿童腹部神经母细胞瘤进行风险分组的潜在影像生物标志物,并可为结构MRI提供附加价值。

研究设计与样本

  • 前瞻性研究,2019年2月至2020年9月纳入133例未治疗的疑似腹部肿瘤患儿,最终分析57例(神经母细胞瘤24例、Wilms瘤18例、肝母细胞瘤15例);采用APT加权成像及定量弛豫时间mapping序列,感兴趣区通过自动伪影检测和ROI缩小算法生成,以ROC分析和Student t检验评估预测性能。

关键影像表现/征象

  • 高危神经母细胞瘤患者的APT加权信号显著高于低危神经母细胞瘤患者(p < .001)。
  • 低危与高危Wilms瘤患者间APT信号差异无统计学意义(p = .69)。
  • 低危与高危肝母细胞瘤患者间APT信号差异无统计学意义(p = .35)。

诊断标准与关键数值

  • APT鉴别低危与高危神经母细胞瘤的AUC为0.93。
  • APT鉴别低危与高危Wilms瘤的AUC为0.58。
  • APT鉴别低危与高危肝母细胞瘤的AUC为0.71。
  • 定量T1和T2值对腹部肿瘤风险分层的AUC为0.61-0.70。

临床应用与阅片要点

  • APT MRI可能作为术前区分儿童腹部神经母细胞瘤风险分组的影像生物标志物,并为结构MRI提供附加价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the potential of molecular amide proton transfer (APT) MRI for predicting the risk group of abdominal tumors in children, and compare it with quantitative T1 and T2 mapping.

METHODS: This prospective study enrolled 133 untreated pediatric patients with suspected abdominal tumors from February 2019 to September 2020. APT-weighted (APTw) imaging and quantitative relaxation time mapping sequences were executed for each subject. The region of interest (ROI) was generated with automatic artifact detection and ROI-shrinking algorithms, within which the APTw, T1, and T2 indices were calculated and compared between different risk groups. The prediction performance of different imaging parameters was assessed with the receiver operating characteristics (ROC) analysis and Student's t-test.

RESULTS: Fifty-seven patients were included in the final analysis, including 24 neuroblastomas (NB), 18 Wilms' tumors (WT), and 15 hepatoblastomas (HB). The APTw signal was significantly (p < .001) higher in patients with high-risk NB than those with low-risk NB, while the difference between patients with low-risk and high-risk WT (p = .69) or HB (p = .35) was not statistically significant. The associated areas under the curve (AUC) for APT to differentiate low-risk and high-risk NB, WT, and HB were 0.93, 0.58, and 0.71, respectively. The quantitative T1 and T2 values generated AUCs of 0.61-0.70 for the risk stratification of abdominal tumors.

CONCLUSIONS: APT MRI is a potential imaging biomarker for stratifying the risk group of pediatric neuroblastoma in the abdomen preoperatively and provides added value to structural MRI.

KEY POINTS: • Amide proton transfer (APT) imaging showed significantly (p < .001) higher values in pediatric patients with high-risk neuroblastoma than those with low-risk neuroblastoma, but did not demonstrate a significant difference in patients with Wilms' tumor (p = .69) or hepatoblastoma (p = .35). • The associated areas under the curve (AUC) for APT to differentiate low-risk and high-risk neuroblastoma, Wilms' tumor, and hepatoblastoma were 0.93, 0.58, and 0.71, respectively. • The quantitative T1 and T2 indices generated AUCs of 0.61-0.70 for dichotomizing the risk group of abdominal tumors.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Jia, Wang, Liang, et al. Risk stratification of abdominal tumors in children with amide proton transfer imaging. Eur Radiol. 2022. PMID: 35031842. doi:10.1007/s00330-021-08376-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。